|
|
Effects of shPLCε on Warburg Effect Through CDC25A in T24 Cells |
Yan-ni HAO1,Ting LI1,Jia-xin FAN1,Luo LI1,Ling-fang NIU1,Li-ping OU1,Xiao-hou WU2,Chun-li LUO1,**() |
1 Key Laboratory of Clinical Diagnostics Founded by Ministry of Education, College of Laboratory,Chongqing Medical University, Chongqing 400016, China 2 Department of Urinary Surgery, The First Affiliated Hospital of Chongqing, Medical University, Chongqing 400016, China |
|
|
Abstract Objective:To study the effect of shPLCε on Warburg effect in bladder cancer and the potential mechanism.Methods:(1) Using lentivirus infecting T24 cells,the glucose consumption and lactate production were detected by the corresponding kit. The expression of PLCε、CDC25A and the molecules related with Warburg effect such as PKM2, GLUT1, LDHA were detected by q-PCR and Western blot. (2)To investigate the related molecular mechanism, using plasimid infecting T24 cells, the expression of CDC25A was detected by q-PCR and Western blot. The expression of molecules related with Warburg effect were detected by Western blot.Result:(1)After reducing the expression of PLCε, glucose consumption and lactate production were significantly decreased in the LV-sh PLCε group,compared with the blank control group and LV-NC group (P<0.01).q-PCR and Western blot showed that the expression of CDC25A, PKM2, GLUT1, LDHA were remarkably lower in LV-shPLCε group than that in blank group and LV-NC group (P<0.05). (2)Western blot showed that the expression of PKM2, GLUT1, LDHA were remarkably lower in shCDC25A group than in blank group and shNC group(P<0.05), after treated with shCDC25A-plasimid.Conclusion:shPLCε can reduce Warburg effect through decreasing the expression of CDC25A in bladder cancer, which can not provide energy for the development and progression of bladder cancer.
|
Received: 24 October 2017
Published: 05 June 2018
|
|
Corresponding Authors:
Chun-li LUO
E-mail: luochunli79@126.com
|
|
|
[1] |
Chen W, Zheng R, Baade P D , et al. Cancer statistics in China, 2015. CA: A Cancer Journal for Clinicians, 2016,66(2):115-132.
doi: 10.3322/caac.21338
|
|
|
[2] |
Warburg O . On the origin of cancer cells. Science, 1956,123(319):309-314.
doi: 10.1126/science.123.3191.309
|
|
|
[3] |
Vander Heiden M G, Cantley L C, Thompson C B . Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science, 2009,324(5930):1029-1033.
doi: 10.1126/science.1160809
|
|
|
[4] |
Henry J, Guillotte A, Luberto C , et al. Characterization of inositol phospho-sphingolipid-phospholipase C 1 (Isc1) in Cryptococcus neoformans reveals unique biochemical features. FEBS Lett, 2011,585(4):635-640.
doi: 10.1016/j.febslet.2011.01.015
pmid: 21256847
|
|
|
[5] |
赵燕, 郝燕妮, 刘南京 , 等. miR-145通过下调PLCε抑制膀胱癌EMT和迁移及其机制研究. 中国生物工程杂志, 2017,37(3):27-36.
|
|
|
[5] |
Zhao Y, Hao Y N, Liu N J , et al. Sillence of PLCε induced by miR-145 inhibits EMT and metastasis in bladder cancer. China Biotechnology, 2017,37(3):27-36.
|
|
|
[6] |
Wind F, Negelein E . The metabolism of tumors in the body. Journal of General Physiology, 1927,8(6):519-530.
doi: 10.1085/jgp.8.6.519
pmid: 2140820
|
|
|
[7] |
Warburg O . Warburg OOn respiratory impairment in cancer cells. Science, 1956,124(3215):269-270.
|
|
|
[8] |
Cairns R A, Harris I S, Mak T W . Regulation of cancer cell metabolism. Nature Reviews Cancer, 2011,11(2):85-95.
doi: 10.1038/nrc2981
|
|
|
[9] |
Cantor J R, Sabatini D M . Cancer cell metabolism: one hallmark, many faces. Cancer Discovery, 2012,2(10):881.
doi: 10.1158/2159-8290.CD-12-0345
pmid: 3491070
|
|
|
[10] |
Hicks S N, Jezyk M R, Gershburg S , et al. General and versatile autoinhibition of PLC isozymes. Mol Cell, 2008,31(3):383-394.
doi: 10.1016/j.molcel.2008.06.018
pmid: 18691970
|
|
|
[11] |
Wing M R, Snyder J T, Sondek J , et al. Direct activation of phospholipase C-epsilon by Rho. J Biol Chem, 2003,278(42):41253-41258.
doi: 10.1074/jbc.M306904200
pmid: 12900402
|
|
|
[12] |
Abnet C C, Freedman N D, Hu N , et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nature Genetics, 2010,42(9):764-776.
doi: 10.1038/ng.649
pmid: 20729852
|
|
|
[13] |
Smrcka A V, Brown J H, Holz G G . Role of phospholipase Cε in physiological phosphoinositide signaling networks. Cellular Signalling, 2012,24(6):1333.
doi: 10.1016/j.cellsig.2012.01.009
|
|
|
[14] |
Alfarouk K O, Verduzco D, Rauch C , et al. Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question. Oncoscience, 2014,1(12):777-802.
doi: 10.18632/oncoscience.109
pmid: 4468317
|
|
|
[15] |
Kim J, Dang C V . Cancer’s molecular sweet tooth and the Warburg effect. Cancer Research, 2006,66(18):8927.
doi: 10.1158/0008-5472.CAN-06-1501
pmid: 16982728
|
|
|
[16] |
Jinno S, Suto K, Nagata A , et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. Embo Journal, 1994,13(7):1549-1556.
doi: 10.1002/j.1460-2075.1994.tb06417.x
pmid: 8156993
|
|
|
[17] |
Kang T, Wei Y, Honaker Y , et al. GSK-3β targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3β inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell, 2008,13(1):36-47.
doi: 10.1016/j.ccr.2007.12.002
pmid: 2276649
|
|
|
[18] |
Ji L, Cao R, Zhang Y , et al. PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis. Nature Communications, 2016,7:12431.
doi: 10.1038/ncomms12431
pmid: 27485204
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|